Vanguard Asset Management 13F: New $147M Stake in CL
Vanguard Asset Management has initiated a stake in Colgate-Palmolive, acquiring 1.6 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Vanguard Asset Management opened a new position of 1,603,022 shares in Colgate-Palmolive Company ($CL), according to a 13F filing with the SEC dated May 8, 2026. It reported 1,603,022 shares worth $146.97 million at the end of the quarter.
Since the filing, $CL is up 0.7% after 1 week, down 1.7% after 1 month and up 8.1% to date (from the $87.05 close on May 8, 2026).
Find the original: Vanguard Asset Management 13F filings on SEC EDGAR
CL
Colgate-Palmolive Company
Key Points
- Vanguard Asset Management has taken a new position in Colgate-Palmolive, acquiring 1.6 million shares valued at $146.6 million.
- Vanguard Asset Management held 1,603,022 $CL shares at quarter end, all of it a new position.
- Shares of NYSE:CL traded near $91.43 on Wednesday, with a market cap of approximately $70.95 billion and a P/E ratio of 34.37.
- Insiders at Colgate-Palmolive, including COO Shane Grant, sold shares recently, while analysts set new price targets ranging from $80 to $102.
Get $CL trade alerts by text
We text you when insiders, Congress or big funds trade $CL. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Colgate-Palmolive Company alert may contain errors. Disclosures
Vanguard Asset Management has opened a new position in Colgate-Palmolive Company (NYSE:CL), acquiring 1,603,022 shares as of its latest SEC filing. This stake is valued at approximately $146.6 million, marking a significant investment in the consumer products giant.
Vanguard Asset Management vs. the S&P 500
Hypothetical returns from Vanguard Asset Management's disclosed trades, not real profit or advice. How we model this.
What Changed in Vanguard Asset Management's Colgate-Palmolive Position
Vanguard Asset Management initiated a new stake in Colgate-Palmolive, acquiring 1,603,022 shares. This represents a completely new position, as the firm held no shares previously. The investment is valued at $146.6 million based on the latest market price.
Other Institutional Activity in Colgate-Palmolive
Among other major funds, BlackRock, Inc. increased its holdings by 2,171,094 shares, bringing its total to 72,643,002 shares worth about $6.19 billion, reflecting a 3.1% increase. Vanguard Capital Management LLC also opened a new position, acquiring 52,219,824 shares valued at roughly $4.45 billion. State Street Corp reduced its stake by 755,303 shares, ending with 47,719,482 shares valued at $4.07 billion, a 1.6% decrease. Price T Rowe Associates Inc /MD/ added 2,541,888 shares, boosting its holdings by 8.2% to 33,729,165 shares worth about $2.87 billion.
Colgate-Palmolive Company Stock Down 1.2%
Shares of NYSE:CL traded near $91.43 on Wednesday. Colgate-Palmolive has a market cap of approximately $70.95 billion, with a P/E ratio of 34.37 and a forward P/E of 21.93. The stock's 52-week range is between $74.55 and $99.33. It has a 50-day moving average of $87.23 and a 200-day moving average of $84.40. The company maintains a current ratio of 1.03 and a quick ratio of 0.56, with a debt-to-equity ratio of 1640.54.
Recent Earnings
In its most recent quarter, Colgate-Palmolive reported revenue of $20.80 billion with a growth rate of 8.4%. The company's net margin was 10.0%, and its return on equity was 3.64%. The next earnings report is scheduled for July 31, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
4 analysts raised price targets.
-
EPS & revenue
EPS met estimates. Revenue missed estimates by 0.9%.
-
Profit surprise
EBITDA missed by 15 percent. Operating income missed by 17 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
4 target raises.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Colgate delivered a solid first quarter with accelerating volume growth, especially in emerging markets and the Hill's pet food business, which grew nearly 5 percent. However, North America oral care remains weak and the company faces significant pressure from rising costs in resins, petrochemicals, and oils, which are expected to be up more than 20 percent year over year. Management is confident in its ability to maintain earnings growth through pricing, innovation, and efficiency programs while continuing to invest in brands.
Guidance The company reaffirmed full year earnings growth in the low to mid single digits. They expect gross margins to decline due to about $300 million in additional raw material and logistics costs tied to oil prices around $110 per barrel. They plan to offset inflation through revenue growth management, innovation, and a $200 million to $300 million cost savings program.
Fine but not compelling. Acceptable results that likely do not create a meaningful forward reset.
Dividend
Colgate-Palmolive pays an annual dividend of $2.12 per share, yielding 2.37% with a payout ratio of 80.62%. The ex-dividend date was not provided.
Insider Buying and Selling at Colgate-Palmolive Company
Recent insider activity at Colgate-Palmolive saw COO Shane Grant sell 23,347 shares at an average price of $90.66 on June 16, 2026. EVP and Controller Malcolm Gregory sold 2,300 shares at $88.44 on May 15, 2026. On May 11, 2026, insiders Lisa Edwards, Kimberly Nelson, Brian Newman, and John Cahill each purchased 2,424 shares, although the price was not disclosed.
Analysts Set New Price Targets
On June 12, 2026, Bernstein initiated coverage with a hold rating and a $96 price target. Barclays maintained its hold rating with an $80 target on May 5, 2026. JP Morgan and UBS both maintained buy ratings with $96 and $100 targets, respectively, on May 4, 2026. RBC Capital reiterated its buy rating with a $102 target on the same day. The consensus among 20 analysts is a buy rating, with a mean price target of $95.85.
About Colgate-Palmolive
Colgate-Palmolive Company is a leading consumer products manufacturer headquartered in New York, NY. It operates in the Household & Personal Products industry within the Consumer Defensive sector. The company produces a range of goods, including oral care, personal care, home care, and pet nutrition products, marketed under well-known brands like Colgate, Palmolive, and Hill's Science Diet. Led by CEO Noel R. Wallace, Colgate-Palmolive employs approximately 33,600 people worldwide.
Bottom Line
Vanguard Asset Management's new investment in Colgate-Palmolive highlights the interest in this established consumer products firm. While 13F filings provide insight into institutional sentiment, they reflect past positions and may not indicate current holdings. Investors watch Colgate-Palmolive for its market stability and consistent dividend payouts, as well as analyst recommendations and insider trading activities.
Related Filing Alerts
Source: Vanguard Asset Management's 13F filing on $CL (May 8, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Vanguard Asset Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts